Cargando…

Abnormal organization of white matter networks in patients with subjective cognitive decline and mild cognitive impairment

Network analysis has been widely used in studying Alzheimer's disease (AD). However, how the white matter network changes in cognitive impaired patients with subjective cognitive decline (SCD) (a symptom emerging during early stage of AD) and amnestic mild cognitive impairment (aMCI) (a pre-dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiao-Ni, Zeng, Yang, Chen, Guan-Qun, Zhang, Yi-He, Li, Xuan-Yu, Hao, Xu-Yang, Yu, Yang, Zhang, Meng, Sheng, Can, Li, Yu-Xia, Sun, Yu, Li, Hong-Yan, Song, Yang, Li, Kun-Cheng, Yan, Tian-Yi, Tang, Xiao-Ying, Han, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226483/
https://www.ncbi.nlm.nih.gov/pubmed/27418146
http://dx.doi.org/10.18632/oncotarget.10601
Descripción
Sumario:Network analysis has been widely used in studying Alzheimer's disease (AD). However, how the white matter network changes in cognitive impaired patients with subjective cognitive decline (SCD) (a symptom emerging during early stage of AD) and amnestic mild cognitive impairment (aMCI) (a pre-dementia stage of AD) is still unclear. Here, structural networks were constructed respectively based on FA and FN for 36 normal controls, 21 SCD patients, and 33 aMCI patients by diffusion tensor imaging and graph theory. Significantly lower efficiency was found in aMCI patients than normal controls (NC). Though not significant, the values in those with SCD were intermediate between aMCI and NC. In addition, our results showed significantly altered betweenness centrality located in right precuneus, calcarine, putamen, and left anterior cingulate in aMCI patients. Furthermore, association was found between network metrics and cognitive impairment. Our study suggests that the structural network properties might be preserved in SCD stage and disrupted in aMCI stage, which may provide novel insights into pathological mechanisms of AD.